RNS Number : 8092I
Colefax Group PLC
21 April 2022
 

AIM: CFX

 

COLEFAX GROUP PLC

 

("Colefax" or "the Group")

 

Full Year Trading Update

 

Since we announced our interim results on 27 January 2022 trading in our two major markets the US and the UK has been ahead of expectations reflecting strong demand for home-related spending. In addition our Decorating Division will deliver an exceptional performance this year due to the timing of completion of a major UK project. Fabric Division profitability is highly operationally geared and as a result of higher than expected sales the Board now expects the Group's profits before tax for the year ended 30 April 2022 to be ahead of market expectations. Like many businesses we are experiencing significant inflationary pressures so although demand is currently strong this adds a note of caution to prospects for the year ahead. 

 

 

Enquiries:

Colefax Group plc

David Green, Chief Executive

Tel: 020 7318 6000

 

Rob Barker, Finance Director

 

KTZ Communications

Katie Tzouliadis  

Dan Mahoney

Tel: 020 3178 6378

Peel Hunt LLP  

(Nominated Advisor

And Broker)

Adrian Trimmings

Andrew Clark

Tel: 020 7418 8900

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTURUNRUVUSUAR